Uploaded January 2025 | Updated September 2026, 3 hours ago
On December 12-13, 2024, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) co-sponsored the 16th Genomic Medicine meeting, Host Genomics and Infectious Disease: Opportunities for Implementing Genomic Medicine, in Bethesda MD. The meeting aimed to identify needs, opportunities, and challenges for applying a patient’s genomic information (genome sequence, transcriptomic, epigenomic, etc. data) in the diagnosis, prevention, and treatment of infectious diseases. Persistent barriers and evidence gaps were examined as opportunities for additional research.
Agenda: genome.gov/GM16
Chapters:
00:00 - Welcome and Introductions (Teri Manolio)
01:27 - Laying the Groundwork - NHGRI Perspective (Eric Green)
06:15 - Laying the Groundwork - NIAID Perspective (Jeane Marrazzo)
15:14 - Structure, Goals, and Products of Prior GM Meetings (Teri Manolio)
20:58 - Keynote 1 (Jennifer Puck)
40:54 - Keynote 2 (Ivan Chinn)
58:01 - Session 1 Discussion
On December 12-13, 2024, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) co-sponsored the 16th Genomic Medicine meeting, Host Genomics and Infectious Disease: Opportunities for Implementing Genomic Medicine, in Bethesda MD. The meeting aimed to identify needs, opportunities, and challenges for applying a patient’s genomic information (genome sequence, transcriptomic, epigenomic, etc. data) in the diagnosis, prevention, and treatment of infectious diseases. Persistent barriers and evidence gaps were examined as opportunities for additional research.
Agenda: genome.gov/GM16
Chapters:
00:00 - Welcome and Introductions (Teri Manolio)
01:27 - Laying the Groundwork - NHGRI Perspective (Eric Green)
06:15 - Laying the Groundwork - NIAID Perspective (Jeane Marrazzo)
15:14 - Structure, Goals, and Products of Prior GM Meetings (Teri Manolio)
20:58 - Keynote 1 (Jennifer Puck)
40:54 - Keynote 2 (Ivan Chinn)
58:01 - Session 1 Discussion










